Show
Sort by
-
- Journal Article
- A1
- open access
Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men
-
Analysis of DNA methylation in cancer : location revisited
-
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics : a decision analytical model
-
Epigenetic risk score improves prostate cancer risk assessment
-
Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men
-
A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients
-
Evaluation of an epigenetic profile for the detection of bladder cancer in patients with hematuria
-
Identification of high-grade prostate cancer using urine-based molecular biomarkers combined with clinical risk factors
-
- Journal Article
- A1
- open access
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
-
Clinical utility of an epigenetic assay to reduce unnecessary repeat prostate biopsies